Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives.
|
Eur J Med Chem
|
2009
|
1.28
|
2
|
Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives.
|
J Med Chem
|
2007
|
1.09
|
3
|
A novel histone acetyltransferase inhibitor modulating Gcn5 network: cyclopentylidene-[4-(4'-chlorophenyl)thiazol-2-yl)hydrazone.
|
J Med Chem
|
2009
|
1.00
|
4
|
Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides.
|
Bioorg Med Chem Lett
|
2010
|
0.93
|
5
|
Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors.
|
Curr Med Chem
|
2006
|
0.92
|
6
|
Synthesis, stereochemical identification, and selective inhibitory activity against human monoamine oxidase-B of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones.
|
J Med Chem
|
2008
|
0.88
|
7
|
Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins.
|
J Med Chem
|
2009
|
0.87
|
8
|
Synthesis and biological evaluation of novel 2,4-disubstituted-1,3-thiazoles as anti-Candida spp. agents.
|
Eur J Med Chem
|
2010
|
0.86
|
9
|
Synthesis, stereochemical separation, and biological evaluation of selective inhibitors of human MAO-B: 1-(4-arylthiazol-2-yl)-2-(3-methylcyclohexylidene)hydrazines.
|
J Med Chem
|
2010
|
0.84
|
10
|
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
|
J Nat Prod
|
2006
|
0.83
|
11
|
Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors.
|
Bioorg Med Chem
|
2010
|
0.83
|
12
|
Synthesis and in vitro selective anti-Helicobacter pylori activity of N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides.
|
Eur J Med Chem
|
2006
|
0.81
|
13
|
Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
|
Chem Biol Drug Des
|
2006
|
0.77
|
14
|
Synthesis and evaluation of 4-acyl-2-thiazolylhydrazone derivatives for anti-Toxoplasma efficacy in vitro.
|
J Med Chem
|
2009
|
0.77
|
15
|
Inhibition of monoamine oxidases by coumarin-3-acyl derivatives: biological activity and computational study.
|
Bioorg Med Chem Lett
|
2004
|
0.77
|
16
|
Analysis of corticosteroids by high performance liquid chromatography-electrospray mass spectrometry.
|
Analyst
|
2004
|
0.76
|
17
|
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors.
|
Bioorg Med Chem
|
2010
|
0.76
|
18
|
Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives.
|
J Med Chem
|
2005
|
0.76
|
19
|
Synthesis and in vitro activity of 2-thiazolylhydrazone derivatives compared with the activity of clotrimazole against clinical isolates of Candida spp.
|
Bioorg Med Chem Lett
|
2007
|
0.76
|
20
|
Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms.
|
BMC Urol
|
2014
|
0.75
|
21
|
Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of N,N'-bis[2-oxo-2H-benzopyran]-3-carboxamides.
|
Bioorg Med Chem Lett
|
2006
|
0.75
|
22
|
A novel class of selective anti-Helicobacter pylori agents 2-oxo-2H-chromene-3-carboxamide derivatives.
|
Bioorg Med Chem Lett
|
2007
|
0.75
|
23
|
Development of an HPLC method for the identification and dosage of non-allowed substances in cosmetic products. Part I: local anaesthetics and antihistaminics.
|
Anal Bioanal Chem
|
2004
|
0.75
|